Hearing Handicap: Clinical Trials

2 trials for Hearing Handicap, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting. 1 Not applicable, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable1Recruiting 1
Phase 11Recruiting 1
Phase 21Recruiting 1

Follow Hearing Handicap: new trials by email Literature Review of Hearing Handicap trials Research Report on Hearing Handicap

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound
Clemastine Fumarate Combined With Engineered Sound, Clemastine Fumarate Combined With Pink Noise, Placebo Drug With Engineered Sound - Central Auditory Processing Disorder, Hearing Impaired (Partially)
Phase 1 / Phase 2RecruitingUniversity of Colorado, Denver3442025-03-312026-04-30
Mediators and Moderators of Auditory Training
STM Training, Speech Training, Mixed Training - Hearing Handicap
Not applicableRecruitingNortheastern University12602025-01-062026-04-20

Narrower conditions

Auditory Diseases, Central (1)  ·  Hearing Disorders (1)  ·  Hearing Loss (1)  ·  Hearing Loss, Hidden (1)  ·  Hearing Loss, Noise-Induced (1)  ·  Hearing Loss, Sensorineural (1)  ·  Language Development Disorders (1)  ·  Presbycusis (1)

Broader conditions

Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Communication Disorders (1)  ·  Ear Diseases (1)  ·  Language Disorders (1)  ·  Nervous System Diseases (1)  ·  Neurobehavioral Manifestations (1)  ·  Neurologic Manifestations (1)  ·  Otorhinolaryngologic Diseases (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Retrocochlear Diseases (1)  ·  Sensation Disorders (1)  ·  Signs and Symptoms (1)

Interventions

Clemastine (1)  ·  Placebo Effect (1)

Sponsors

Northeastern University (1)  ·  University of Colorado, Denver (1)

Countries

United States (2)

Top investigators

Aaron Seitz, PhD (1)  ·  Achim Klug, PhD (1)  ·  Samuel A Budoff, PhD, MS (1)  ·  Tess Koerner, PhD (1)